124 related articles for article (PubMed ID: 26773190)
1. Elevation of HLA-G-expressing DC-10 cells in patients with gastric cancer.
Xu DP; Shi WW; Zhang TT; Lv HY; Li JB; Lin A; Yan WH
Hum Immunol; 2016 Sep; 77(9):800-4. PubMed ID: 26773190
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
5. Expansion of CD4(+) HLA-G(+) T Cell in human pregnancy is impaired in pre-eclampsia.
Hsu P; Santner-Nanan B; Joung S; Peek MJ; Nanan R
Am J Reprod Immunol; 2014 Mar; 71(3):217-28. PubMed ID: 24383466
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.
Locafaro G; Amodio G; Tomasoni D; Tresoldi C; Ciceri F; Gregori S
J Immunol Res; 2014; 2014():636292. PubMed ID: 24741612
[TBL] [Abstract][Full Text] [Related]
7. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
8. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
Shi WW; Lin A; Xu DP; Bao WG; Zhang JG; Chen SY; Li J; Yan WH
Hum Immunol; 2011 Nov; 72(11):1068-73. PubMed ID: 21762747
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
[TBL] [Abstract][Full Text] [Related]
11. HLA-G expression levels influence the tolerogenic activity of human DC-10.
Amodio G; Comi M; Tomasoni D; Gianolini ME; Rizzo R; LeMaoult J; Roncarolo MG; Gregori S
Haematologica; 2015 Apr; 100(4):548-57. PubMed ID: 25661445
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory function of HLA-G in gastric cancer.
Tuncel T; Karagoz B; Haholu A; Ozgun A; Emirzeoglu L; Bilgi O; Kandemir EG
Asian Pac J Cancer Prev; 2013; 14(12):7681-4. PubMed ID: 24460353
[TBL] [Abstract][Full Text] [Related]
13. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Gregori S; Magnani CF; Roncarolo MG
Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
[TBL] [Abstract][Full Text] [Related]
14. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
15. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
16. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
[TBL] [Abstract][Full Text] [Related]
17. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
[TBL] [Abstract][Full Text] [Related]
19. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy.
Amodio G; Mugione A; Sanchez AM; Viganò P; Candiani M; Somigliana E; Roncarolo MG; Panina-Bordignon P; Gregori S
Hum Immunol; 2013 Apr; 74(4):406-11. PubMed ID: 23238214
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer.
Mejía-Guarnizo LV; Monroy-Camacho PS; Rincón-Rodríguez DE; Rincón-Riveros A; Martinez-Vargas DA; Huertas-Caro CA; Oliveros-Wilches R; Sanchez-Pedraza R; Nuñez-Lemus M; Cristancho-Lievano CF; Castellanos-Moreno AM; Martinez-Correa LM; Rodríguez-García JA
Sci Rep; 2023 Aug; 13(1):13119. PubMed ID: 37573450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
